Dengue Virus Type 3, South Pacific Islands, 2013
, Claudine Roche, Didier Musso, Henri-Pierre Mallet, Tenneth Dalipanda, Alfred Dofai, Francisco Nogareda, Eric J. Nilles, and John Aaskov
Author affiliations: Institut Louis Malardé, Papeete, Tahiti, French Polynesia (V.-M. Cao-Lormeau, C. Roche, D. Musso); Direction de la Santé, Papeete (H.-P. Mallet); Ministry of Health and Medical Services, Honiara, Solomon Islands (T. Dalipanda); National Referral Hospital, Honiara (A. Dofai); World Health Organization, Suva, Fiji (F. Nogareda, E.J. Nilles); Queensland University of Technology, Brisbane, Queensland, Australia (J. Aaskov)
Figure 1. South Pacific Region showing the study areas (Solomon Islands and French Polynesia) tested for dengue virus type 3.
Page created: May 16, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.